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We conducted a retrospective study to examine trends 
in latent tuberculosis infection (LTBI) and TB disease rates 
among  homeless  persons  in  shelters  in  New  York,  NY, 
1992–2006. Although TB case rates fell from 1,502/100,000 
population to 0, a 31% LTBI rate in 2006 shows the value of 
identifying and treating TB in the homeless.  
T
uberculosis skin testing (TST) at homeless shelters and 
drop-in centers is a standard component of tuberculo-
sis  (TB)  transmission  control.  Since  1969,  St.  Vincent’s 
Hospital has cared for homeless persons in New York City 
(NYC) (1), and 37 shelters and drop-in centers were served 
in 2006. We report latent tuberculosis infection (LTBI) and 
TB disease data from the 8 largest of these sites from Janu-
ary 1992 through June 2006. TB screening began at the larg-
est (site 1) in January 1992 and at the others in 1997 through 
1999 (Table 1). Because the NYC homeless population is 
diverse, the populations served by shelters have qualitative-
ly and quantitatively different LTBI risk factors. Sites 1–3 
are men’s shelters, site 8 is a women’s drop-in center, and 
sites 4–7 are drop-in centers for both men and women. At 
the sites, medical teams assess persons’ TB status using a 
standard questionnaire and, when indicated, TST. The ques-
tionnaire was designed to elicit TB history, prior skin test 
results, LTBI treatment, and risk factors, including those for 
progression to TB disease, such as HIV infection. During 
the time encompassed by this study, St. Vincent’s Hospi-
tal initiated 32,108 TB evaluations of homeless persons at 
these 8 sites; 28,835 (89.8%) were completed.
The Study
We designed and conducted a retrospective, descrip-
tive study to examine trends in LTBI and TB disease rates 
among homeless persons at the selected sites. Our dataset 
was limited to the following categories: age, sex, race/eth-
nicity, prior TST status, HIV test status, and LTBI treat-
ment  history.  Those  with  no  previous  TST,  prior  nega-
tive tests, or unclear prior test results were offered a TB 
evaluation. TST was not offered to those with a convincing 
past history of TB or a documented or convincing history 
of a previous positive TST result (explanation in online 
Technical  Appendix,  available  from  www.cdc.gov/EID/
content/15/7/1109-Techapp.pdf). We classified each per-
son as follows: TST negative, TST positive as tested, TST 
positive  by  history,  TB  disease,  and  noncompliant  with 
skin testing reading.
The number of single adult homeless persons identi-
fied by the yearly census of the New York City Depart-
ment of Homeless Services ranged from 27,846 in 1992 
to 29,348 in 2005 (2), while the number and proportion of 
TST screenings by our program increased from 972 (3% of 
New York City total) in 1992 to 4,093 (13.9%) in 2005, the 
last complete year of our data.
Among the 32,108 attempted TB screenings, 28,835 
persons (89.8%) completed the screening process; 11,385 
had positive TST results or history (Table 2). We strati-
fied TST data from all sites and compared those from site 1 
(58.1% of observations) to those from sites 2–8 combined, 
for all years. Using a nonparametric test for trend across 
ordered groups (developed by Cuzick [3] as an extension of 
the Wilcoxon rank-sum test), we found the 4 testing groups 
each had statistically significant negative trends by year: 
site 1 test only, z = –3.64, p<0.001; site 1 test and history, 
z = –3.35, p = 0.001; sites 2–8 test only, z = –2.91, p = 
0.004; sites 2–8 test and history, z = –2.95, p = 0.003 (Stata 
10.1 manual: nptrend test) (4). The statistically significant 
decreasing trends for the TST and TST positive by history 
groups for both site 1 and the other sites combined, from 
the inception of the data collection, are shown in Figure 1.
Overall, when the categories of administered TST and 
TST positivity by history were combined as indicators of 
LTBI, results decreased from 58.1% to 30.9% (1992–2006) 
at site 1 and from 57.3% to 30.8% at sites 2–8 combined 
(1997–2006) (online Technical Appendix Table 1). Since 
few persons with a history of TST provided documenta-
tion, we examined LTBI rates among those persons actu-
ally tested. By this criterion, TST positivity decreased from 
40.1% to 9.8% at site 1 (1992–2006) and from 30.4% to 
13.3% at sites 2–8 combined (1997–2006).
TB disease rates at all 8 sites combined (Figure 2) also 
decreased in the screened population over the study period. 
Sixty-three persons with TB disease were identified from 
January 1992 through June 2006. In 1992, the calculated 
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171/100,000 in 2004. These rates are far greater than for the 
general New York City population (13.0/100,000) and the 
United States population (4.4/100,000) in 2007 (5). From 
January 2005 through June 2006, no cases were identified. 
Treatment history was included in the TB questionnaire 
starting in 1996. The percentage of persons with a histo-
ry of positive TST and who received >6 months of treat-
ment trended upward, from 50.0% in 1996 through 1997 to 
84.2% in 2006 (online Technical Appendix Figure).
Using logistic regression, we modeled the risk factors 
(online Technical Appendix Tables 1–4), and the probabili-
ty of being TB positive (by test or history) and of not having 
the TB test read. For TB positivity, the adjusted odds ratio 
(OR) for each age group compared with that for the young-
est age group was significant and increased linearly with 
age. In general, the OR increased by a factor of 2 for each 
advancing age group (online Technical Appendix Table 3). 
Regarding compliance in TST reading, being in an older 
group was protective (online Technical Appendix Table 3).
We were able to assess changes in HIV-positivity rates 
from January 2001 through June 2006. The percentage fluc-
tuated between 2.1% and 3.1%. The stage of HIV disease 
(from asymptomatic HIV-antibody positive to AIDS) was 
not recorded. For comparison, during this period in New 
York City, the number of persons who received a diagno-
sis of AIDS each year decreased from 5,616 to 3,672 (6). 
Because the percentage of HIV antibody positivity among 
those screened was essentially constant during the study 
period, we believe that the decreasing LTBI rates (repre-
sented by TST positive as tested) are real and not due to 
increasing numbers of persons with advanced HIV disease 
who are unable to mount an appropriate skin test response.
Our acceptance of a compelling history of prior posi-
tive TST rather than retesting may have resulted in inac-
curate reporting of LTBI rates. However, we decided to ac-
cept compelling histories on the basis of decades of clinical 
experience in caring for homeless persons, experience in 
completing forms in the same way over the study years, and 
by a desire to do no harm. Our population is not a random 
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Table 1. Number of tuberculin skin test screenings, by site, New York, NY, USA, January 1992–June 2006 
Shelters Drop-in centers
Year  1 2 3 4 5 6 7 8 Total 
1992 972 – – – – – – – 972
1993 802 – – – – – – – 802
1994 822 – – – – – – – 822
1995 967 – – – – – – – 967
1996 1,419 – – – – – – – 1,419
1997 1,320 141 45 – – – – – 1,506
1998 1,208 533 160 2 6 6 – 3 1,918
1999 1,110 550 172 172 167 112 131 151 2,565
2000 1,141 628 114 187 173 166 113 167 2,689
2001 1,153 740 243 180 169 159 91 86 2,821
2002 1,147 717 428 157 141 150 117 85 2,942
2003 1,441 782 441 132 134 96 122 46 3,194
2004 1,548 1,065 209 126 132 86 93 87 3,346
2005 1,958 1,443 78 127 182 145 121 39 4,093
2006* 1,016 722 17 66 91 85 51 4 2,052
Total 18,024 7,321 1,907 1,149 1,195 1,005 839 668 32,108
*January–June. 
Table 2. Results of TB screenings, New York, NY, USA, January 
1992–June 2006* 
TB screening status  No. (%)
Noncompliant with skin test reading 3,273 (NA)†
TST– 17,368 (60.4)
TST+ 3,597 (12.5)
TST+ by history 7,788 (27.1)
Active TB 63 (<1.0)
Anergic‡ 19 (<1.0)
Total completing evaluation 28,835 (100.0)
*TB, tuberculosis; TST, tuberculin skin testing; NA, not applicable. 
†The denominator includes all those persons for whom TST status 
became known. Those noncompliant with TST interpretation have not 
been included. Thus, in online Technical Appendix Table 4 (available from 
www.cdc.gov/EID/content/15/7/1109-Techapp.pdf), the percentage of such 
persons is NA. 
‡No reaction to TST, mumps virus, Candida spp. 
Figure 1. Tuberculin skin test positivity by site and year, New York, 
NY, USA, January 1992–June 2006.TB among Homeless, New York, 1992–2006
sample and may not represent the total homeless popula-
tion within the city, raising concern about the generaliz-
ability of our findings. Also, because the results of all TST 
screenings were included in our analysis, persons who were 
screened multiple times are overrepresented. Of 32,108 at-
tempted  screenings,  4,724  (14.7%)  persons  received  >1 
evaluation. Also, the number of screenings at each site over 
the years varied, depending on changing requirements of 
the shelter program.
In the past 2 decades, major public health efforts have 
been made to evaluate and treat persons with both TB dis-
ease and LTBI. Our analysis offers evidence that these at-
tempts to control TB in the homeless population have been 
beneficial (7–9).
Although case rates of TB disease are carefully mea-
sured by public health authorities throughout the United 
States, this is not true for LTBI rates. Therefore, we cannot 
directly compare the rates of LTBI among these homeless 
persons to those among the general population. However, 
the rates of LTBI and TB disease observed in this study 
may serve as a valuable resource for TB control planning. 
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Figure 2. Tuberculosis disease case rates (per 
100,000)  and  infection  rates  (as  tested)  by 
year,  New  York,  NY,  USA,  1992–2006. ATB, 
active  tuberculosis;  LTBI,  latent  tuberculosis 
infection.
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